1 January 2022

Socialstyrelsen said puberty blockers and cross-sex hormones should ordinarily be provided within research, with excepti

Name: Socialstyrelsen said puberty blockers and cross-sex hormones should ordinarily be provided within research, with excepti
Start: 2022-01-01
Location: Europe

Socialstyrelsen said puberty blockers and cross-sex hormones should ordinarily be provided within research, with exceptional individual use pending such studies (Socialstyrelsen, 2022).

Source: Policy change regarding hormonal treatment of minors with gender dysphoria, K2021-3343 (Karolinska University Hospital, 2021)

Jurisdiction: Europe

Read the dossier on this country